{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T01:39:20Z","timestamp":1786757960753,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.mycmed.2019.04.003","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T08:16:33Z","timestamp":1555920993000},"page":"147-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Activity of base analogues (5-fluorouracil, 5-flucytosine) against planktonic cells and mature biofilm of Candida yeast. Effect of combination with folinic acid"],"prefix":"10.1016","volume":"29","author":[{"given":"J.","family":"Kr\u00f3l","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Nawrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bartoszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2019.04.003_bib0160","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2147\/IDR.S156633","article-title":"Epidemiology, practice patterns, and prognostic factors for candidemia; and characteristics of fourteen patients with breakthrough Candida bloodstream infections: a single tertiary hospital experience in Japan","volume":"11","author":"Hirano","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0165","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/yea.3019","article-title":"Candida glabrata: a deadly companion?","volume":"31","author":"Bolotin-Fukuhara","year":"2014","journal-title":"Yeast"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0170","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1365-2958.2006.05235.x","article-title":"Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies","volume":"61","author":"Vermitsky","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0175","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3201\/eid2011.140685","article-title":"Drug-resistant Candida glabrata infection in cancer patients","volume":"20","author":"Farmakiotis","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0180","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1471-2334-14-188","article-title":"Isolation of cholesterol-dependent, multidrug-resistant Candida glabrata strains from blood cultures of a candidemia patient in Kuwait","volume":"8","author":"Khan","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0185","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/513663","article-title":"The epidemiology of hematogeneous candidiasis caused by different Candida species","volume":"24","author":"Abi-Said","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0190","first-page":"1","article-title":"Biofilms. Cold Spring Harb","volume":"2","author":"L\u00f3pez","year":"2010","journal-title":"Perspect Biol"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0195","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3389\/fmicb.2018.01196","article-title":"The Impact of Biofilm Formation on the Persistence of Candidemia","volume":"4","author":"Li","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.MB-0020-2015","article-title":"Development, Architecture, and Resistance","volume":"3","author":"Chandra","year":"2015","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0205","first-page":"1","article-title":"Candida glabrata Biofilms: how far have we come?","volume":"3","author":"Rodrigues","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0210","first-page":"1","article-title":"Adhesins in Candida glabrata","volume":"20","author":"Timmermans","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0215","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1128\/AAC.01111-13","article-title":"Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method","volume":"57","author":"Howard","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0220","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003495-200969030-00010","article-title":"Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections","volume":"69","author":"Moen","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0225","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2147\/DDDT.S91730","article-title":"Liposomal flucytosine capped with gold nanoparticle formulations for improved ocular delivery","volume":"13","author":"Salem","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0230","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology; clinical indications; pharmacokinetics; toxicity and drug interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/1120009X.1990.11738998","article-title":"Biochemical rationale for the 5-fluorouracil leucovorin combination and update of clinical experience","volume":"2","author":"Rustum","year":"1990","journal-title":"J Chemother"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0240","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mycmed.2018.11.002","article-title":"The susceptibility of Candida albicans strains to selected anticancer drugs and flucytosine, relevance of the presence of self-splicing intron in 25S rDNA","volume":"29","author":"Kr\u00f3l","year":"2018","journal-title":"J Mycol Med"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0245","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1469-0691.2012.03880.x","article-title":"EUCAST-AFST. EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0250","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1128\/AAC.46.11.3518-3521.2002","article-title":"In vitro activities of 5-fluorocytosine against 8;803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods","volume":"46","author":"Pfaller","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0255","unstructured":"European Committee on Antimicrobial Susceptibility Testing Antifungal Agents Breakpoint tables for interpretation of MICs Version 9.0; valid from 2018-02-12. http:\/\/www.eucast.org\/clinical_breakpoints\/. [accessed 10. 10. 2018]."},{"key":"10.1016\/j.mycmed.2019.04.003_bib0260","first-page":"1","article-title":"Microtiter dish biofilm formation assay","volume":"30","author":"O\u2019Toole","year":"2011","journal-title":"J Vis Exp"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0265","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1093\/nar\/21.25.6020","article-title":"Correlation between the presence of a self-splicing intron in the 25S rDNA of C. albicans and strains susceptibility to 5-fluorocytosine","volume":"21","author":"Mercure","year":"1993","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0270","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1590\/S1517-83822013000300029","article-title":"Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans","volume":"44","author":"Routh","year":"2014","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0275","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1128\/JCM.43.12.6215-6216.2005","article-title":"oyee AG. 5-fluorouracil altered morphology and inhibited growth of Candida albicans","volume":"43","author":"Kesavan","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0280","doi-asserted-by":"crossref","first-page":"163","DOI":"10.15698\/mic2015.05.202","article-title":"Exogenous folates stimulate growth and budding of Candida glabrata","volume":"2","author":"Porzoor","year":"2015","journal-title":"Microb Cell"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0285","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ijantimicag.2006.07.012","article-title":"Antifolates as antimycotics? Connection between the folic acid cycle and the ergosterol biosynthesis pathway in Candida albicans","volume":"28","author":"Navarro-Mart\u00ednez","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0290","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/mmy\/myv108","article-title":"In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm","volume":"54","author":"Pesee","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0295","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1128\/AAC.48.9.3291-3297.2004","article-title":"Penetration of Candida biofilms by antifungal agents","volume":"48","author":"Al-Fattani","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0300","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2217\/fmb.13.101","article-title":"Mechanisms of Candida biofilm drug resistance","volume":"8","author":"Taff","year":"2013","journal-title":"Future Microbiol"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0305","first-page":"1","article-title":"A review of the evolution of systemic chemotherapy in the management of colorectal cancer","volume":"14","author":"Gustavsson","year":"2015","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.mycmed.2019.04.003_bib0310","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1097\/CCM.0b013e3181f265ba","article-title":"5-FU Catheter Study Groooooup. Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine\/silver sulfadiazine in preventing catheter colonization","volume":"38","author":"Walz","year":"2010","journal-title":"Crit Care Med"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523319300149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523319300149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:19:04Z","timestamp":1761110344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523319300149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1156523319300149"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2019.04.003","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity of base analogues (5-fluorouracil, 5-flucytosine) against planktonic cells and mature biofilm of Candida yeast. Effect of combination with folinic acid","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2019.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}